Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: August 2011

Chapter 3 - Secondary hallucinations

from Section 1 - Introduction

Related content

Powered by UNSILO


1. Sarbin T. R., Juhasz J. B. (1975).The social context of hallucinations. In Hallucinations: behavior, experience and theory, Siegel R. and West L. (Eds). New York: John Wiley & Sons.
2. Slade P., Bentall R. (1988). Sensory definition: a scientific analysis of a hallucination. Baltimore: Johns Hopkins University Press.
3. David A. The cognitive neuropsychiatry of auditory verbal hallucinations: an overview. Cogn Neuropsychiatry, 2004. 9:107–23.
4. Carter M., Mackinnon A., Copolov D. Patients’ strategies for coping with auditory hallucinations. J Nerv Ment Dis, 1996. 184:159–64.
5. Ohayon M. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res, 2000. 97:153–64.
6. Mueser K. T., Bellack A. S., Brady E. U. Hallucinations in schizophrenia. Acta Psychiatr Scand, 1990. 82:26–9.
7. Johns L., et al. Occurrence of hallucinatory experiences in a community sample and ethnic variations. Br J Psychiatry, 2002. 180:174–8.
8. Johns L., van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev, 2001. 21:1125–41.
9. Krabbendm L., et al. Explaining transitions over the hypothesized psychosis continuum. Aust NZ J Psychiatry, 2005. 39:180–6.
10. van Os J., et al. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Arch Gen Psychiatry, 2001. 58:663–8.
11. Levine E., Jonas H., Serper M. Interpersonal attributional biases in hallucinatory-prone individuals. Schizophr Res, 2004. 69:23–8.
12. Laroi F., Collignon O., Van Der Linden M. Source monitoring for actions in hallucination proneness. Cogn Neuropsychiatry, 2005. 10:105–23.
13. Aleman A., et al. Mental imagery and perception in hallucinationprone individuals. J Nerv Ment Dis, 2000. 188:830–6.
14. Morrison A., Wells A., Nothard S. Cognitive factors in predisposition to auditory and visual hallucinations. Br J Clin Psychol, 2000. 39:67–78.
15. Sartorius N., Shapiro R., Jablensky A. The international pilot study of schizophrenia. Schizophr Bull, 1974. 1:21–5.
16. Bracha H., et al. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry, 1989. 146:526–8.
17. Zarroug E. The frequency of visual hallucinations in schizophrenic patients in Saudi Arabia. Br J Psychiatry, 1975. 127:553–5.
18. Suhail K., Cochrane R. Effect of culture and environment on the phenomenology of delusions and hallucinations. Int J Soc Psychiatry, 2002. 48:126–38.
19. Goldberg S., Klerman G., Cole J. Changes in schizophrenic psychology and ward behaviour as a function of phenothiazine treatment. Br J Psychiatry, 1965. 111:120–33.
20. Baethge C., et al. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord, 2005. 7:136–45.
21. Brasic J. Hallucinations. Percept Mot Skills, 1998. 86:851–77.
22. Cummings J., Miller B. Visual hallucinations: clinical occurrence and use in differential diagnosis. West Med J, 1987. 146:46–51.
23. Cornelius J., et al. Characterizing organic hallucinosis. Compr Psychiatry, 1991. 32:338–44.
24. Cutting J. The phenomenology of acute organic psychosis. Comparison with acute schizophrenia. Br J Psychiatry, 1997. 151:324–32.
25. Johnstone E., et al. Phenomenology of organic and functional psychoses and the overlap between them. Br J Psychiatry, 1988. 153:770–6.
26. Asaad G., Shapiro B. Hallucinations: theoretical and clinical overview. Am J Psychiatry, 1986. 143:1088–97.
27. Ffytche D. Visual hallucination and illusion disorders: a clinical guide. Adv Clin Neurosci Rehabil, 2004. 4:16–18.
28. Santhouse A., Howard R., Ffytche D. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain, 2000. 123:2055–64.
29. Mocellin R., Walterfang M., Velakoulis D. The neuropsychiatry of complex visual hallucinations. Aust NZ J Psychiatry, 2006. 40:742–51.
30. Lindal E., Stefansson J., Stefansson S. The qualitative difference of visions and visual hallucinations: a comparison of a general-population and clinical sample. Compr Psychiatry, 1994. 35:405–8.
31. LaBarre W. (1975). Anthropological perspectives on hallucination and hallucinogens. In Hallucinations: Behaviour, Experience and Theory, Siegel R. and West C. (Eds.). New York: John Wiley & Sons.
32. Ohayon M., et al. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry, 1996. 169:459–67.
33. Hurlock E., Burnstein M. The imaginary playmate: a questionnaire study. J Genet Psychol, 1932. 41:380–92.
34. Svendsen M. Children's imaginary companions. Arch Neurol Psychiatry, 1934. 12:985–9.
35. Schaeffer C. Imaginary companions and creative adolescents. Dev Psychol, 1969. 1:747–9.
36. Bonne O., et al. Childhood imaginary companionship and mental health in adolescence. Child Psychiatry Hum Dev, 1999. 29:277–86.
37. Simonds J. Hallucinations in nonpsychotic children and adolescents. J Youth Adolesc, 1975. 4:171–82.
38. Balk D. Adolescents’ grief reactions and self-concept perceptions following sibling death: a study of 33 teenagers. J Youth Adolesc, 1983. 12:137–61.
39. Adair D., Keshavan M. The Charles Bonnet Syndrome and grief reaction. Am J Psychiatry, 1988. 145:895.
40. Olson P., Suddeth J., Peterson P. Hallucinations of widowhood. J Am Geriatr Soc, 1985. 33:543–7.
41. Grimby A. Bereavement among elderly people: grief reactions, post-bereavement hallucinations and quality of life. Acta Psychiatr Scand, 1993. 87:72–80.
42. Mullaney D., et al. Effects of sustained continuous performance on subjects working alone and in pairs. Percept Mot Skills, 1983. 57:819–32.
43. Mullaney D., et al. Sleep loss and nap effects on sustained continuous performance. Psychophysiology, 1983. 20:643–51.
44. Forrer G. Benign auditory and visual hallucinations. Arch Gen Psychiatry, 1964. 3:95–8.
45. Walsh F., Hoyt W. (1969). Clinical neuro-ophthalmology. 3rd ed. Baltimore: Williams & Wilkins.
46. Penfield W., Perot P. The brain's record of auditory and visual experience: a final summary and discussion. Brain, 1963. 86:595–96.
47. West C. (1962). Hallucinations. New York: Grune & Stratton.
48. Cogan D. Visual hallucinations as release phenomena. Graefes Arch Clin Exp Opthal, 1973. 188:139–50.
49. Manford M., Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain, 1998. 121:1819–40.
50. Ffytche D., Howard R. The perceptual consequences of visual loss: ‘positive’ pathologies of vision. Brain, 1999. 122:1247–60.
51. Ffytche D., et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nature Neurosci, 1998. 1:738–42.
52. Howard R., et al. Seeing visual hallucinations with functional magnetic resonance imaging. Dement Geriatr Cogn Disord, 1997. 8:73–77.
53. Lepore F. Spontaneous visual phenomena with visual loss: 104 patients with lesions of retinal and neural afferent pathways. Neurology, 1990. 40:444–7.
54. Galasko D., Kwo-On-Yuen P., Thal L. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am, 1988. 11:151–66.
55. Perry E., Perry R. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn, 1995. 28:240–58.
56. Perry E., et al. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging, 1992. 13:393–400.
57. Glennon R., Titeler M., McKenney J. Evidence for 5HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci, 1984. 35:2505–11.
58. Abraham H., Aldridge A., Gogia P. The psychopharmacology of hallucinogens. Psychopharmacology, 1996. 14:285–98.
59. Goetz C., et al. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology, 1998. 51:811–14.
60. Angrist B., et al. Amphetamine psychosis: behavioural and biochemical aspects. J Psychiatr Res., 1974. 11:13–23.
61. Dubois B., et al. Cholinergic dependent cognitive deficits in Parkinson's disease. Ann Neurol., 1987. 22:26–30.
62. Perry E., et al. Evidence of a monoaminergic–cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem., 1991. 55:1454–6.
63. McKeith I., et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 2000. 356:2031–6.
64. Packard R. Delirium. Neurologist, 2001. 7:327–40.
65. Brown T. (2000). Basic mechanisms in the pathogenesis of delirium. In Psychiatric care of the medical patient, Stoudemire A., Fogel B., Greenberg D. (Eds.). New York: Oxford University Press, pp. 571–80.
66. Nevo I., Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int., 1995. 26:305–36.
67. Collerton D., Perry E., McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci., 2005. 28:737–94.
68. Ndetei D., Singh A. Hallucinations in Kenyan schizophrenic patients. Acta Psychiatr Scand., 1983. 67:144–7.
69. Roberts J. (1984). Differential diagnosis in neuropsychiatry. New York: John Wiley & Sons.
70. David A. Auditory hallucinations: phenomenology, neuropsychology and neuroimaging update. Acta Psychiatr Scand Suppl, 1999. 395:95–104.
71. Posner M., et al. Asymmetries in hemispheric control of attention in schizophrenia. Arch Gen Psychiatry, 1988. 45:814–21.
72. DiGirolamo G., Posner M. Attention and schizophrenia: a view from cognitive neuroscience. Cogn Neuropsychiatry, 1996. 1:95–102.
73. Chen Y., et al. Motion perception in schizophrenia. Arch Gen Psychiatry, 1999. 56:149–54.
74. Gabrovska V., et al. Evidence for an associative visual agnosia in schizophrenia. Schizophr Res, 2002. 59:277–86.
75. Slaghuis W., Bakker V. Forward and backward visual masking of contour by light in positive symptom and negative symptom schizophrenia. J Abnorm Psychol, 1995. 104:41–54.
76. Selemon L., Rajkowska G., Goldman-Rakic P. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry, 1995. 52:805–18.
77. Tadin D., et al. Believing is seeing in schizophrenia: the role of top-down processing. Behav Brain Sci, 2005. 28:775.
78. Trzepacz P. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry, 2000. 5:132–48.
79. Flacker J., Lipsitz L. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol, 1999. 54:8239–46.
80. Cowen M., Lawrence A. The role of opioid–dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropharmacol Biol Psychiatry, 1999. 23:1171–212.
81. Piazza P., Le Moal M. Glucocorticoids as a substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev, 1997. 23:359–72.
82. Gaudreau J., Gagnon P. Psychogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses, 2005. 64:471–5.
83. Braun C., et al. Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psych Neurosci, 2003. 28:432–9.
84. Teunisse R., et al. Visual hallucinations in psychologically normal people: Charles Bonnet's Syndrome. Lancet, 1996. 347:794–7.
85. Bonnet C. (1769). Essai Analytique Sur les Facultés de L’âme. 2nd ed., Copenhague: Philbert.
86. Holroyd S., Shepherd M., Downs J. Occipital atrophy is associated with visual hallucinations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci, 2000. 12:25–8.
87. Lhermitte M. Syndrome de la calotte due penduncule cerebral. Les troubels psycho-sensoriels dans les lesions du mesocephale. Revue de Neurologique (Paris), 1922. 38:1359–65.
88. Bassiony M., Lyketsos C. Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics, 2003. 44:388–401.
89. Lin S., Yu C., Pai M. The occipital white matter lesions in Alzheimer's disease patients with visual hallucinations. Clin Imaging, 2006. 30:388–93.
90. Lewis D., et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci, 1987. 7:1799–1808.
91. Foerster O. The cerebral cortex in man. Lancet, 1931. 2:309–19.
92. Chapman F., et al. Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry, 1999. 156:1983–5.
93. Barnes J., David A. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry, 2001. 70:727–33.
94. Mosimann M., et al. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology, 2004. 63:2091–6.
95. Bohnen N., et al. Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol Psychiatry, 2003. 60:1745–8.
96. Harding A., Broe G., Halliday G. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain, 2002. 125:391–403.
97. Halliday G., et al. Loss of brainstem and serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res, 1990. 510:104–7.
98. Jellinger K. New developments in the pathology of Parkinson's disease. Adv Neurol, 1990. 53:1–16.
99. Bodis-Wollner I., Tagliati M. The visual system in Parkinson's disease. Adv Neurol, 1993. 60:390–4.
100. Collerton D., et al. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual–perceptual and attentional–executive dementia. Dement Geriatr Cogn Disord, 2003. 16:229–37.
101. Young B. A phenomenological comparison of LSD and schizophrenic states. Br J Psychiatry, 1974. 124:64–74.
102. Marek G., et al. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience, 2001. 105:379–92.
103. Aghajanian G., Marek G. Serotonin and hallucinogens. Neuropsychopharmacology, 1999. 21:S16–S23.
104. Sarter M., Bruno J. Cortical acetylcholine, reality distortion, schizophrenia and Lewy body dementia: too much or too little acetylcholine? Brain Cogn, 1998. 38:297–316.
105. Cancelli I., Marcon G., Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol, 2004. 19:577–84.
106. Moore H., et al. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience, 1998. 88:811–22.
107. Lipowski Z. (1980). Delirium due to alcohol and drug withdrawal. In Delirium: Acute Brain Failure in Man, Lipowski Z. (Ed.). Charles Springfield: C. Thomas, pp. 317–43.
108. MacKinnon G., Parker W. Benzodiazepine withdrawal syndrome: a literature review and evaluation. Am J Drug Alcohol Abuse, 1982. 9:19–33.
109. Dyer J., Roth B., Hyma B. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med, 2001. 37:147–53.
110. Krystal J., et al. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry, 2006. 63:957–68.
111. Malcolm R. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry, 2003. 64 Suppl 3:36–40.
112. Faingold C., Gouemo P. N., Riaz A. Ethanol and neurotransmitter interactions – from molecular to integrative effects. Prog Neurobiol, 1998. 55:509–35.
113. Eysel U., et al. Reorganization in the visual cortex after retinal and cortical damage. Restor Neurol Neurosci, 1999. 15:153–64.
114. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry, 2002. 73:535–41.
115. Paulig M., Mentrup H. Charles Bonnet's Syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry, 2001. 70:813–14.
116. Gibson K., et al. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). Biol Psychiatry, 2003. 54:763–8.
117. Ohayon M. M., et al. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry, 1996. 169(4):459–67.
118. Cheyne J. A., Rueffer S. D., Newby-Clark I. R. Hypnagogic and hypnopompic hallucinations during sleep paralysis: neurological and cultural construction of the nightmare. Conscious Cogn, 1999. 8(3):319–37.
119. Takata K., et al. Night-time hypnopompic visual hallucinations related to REM sleep disorder. Psychiatry Clin Neurosci, 1998. 52(2):207–9.
120. Baguley D.M. Hyperacusis. J R Soc Med, 2003. 96(12):582–5.
121. Gothelf D., et al. Hyperacusis in Williams Syndrome: characteristics and associated neuroaudiologic abnormalities. Neurology, 2006. 66(3):390–5.
122. Lee H., et al. Hearing symptoms in migrainous infarction. Arch Neurol, 2003. 60(1):113–6.
123. Sims A. P. (2002). Symptoms in the mind. An introduction to descriptive psychopathology. 3rd ed. London: W. B. Saunders Company.
124. Yagcioglu S., Ungan P. The ‘Franssen’ illusion for short duration tones is preattentive: a study using mismatch negativity. Brain Res, 2006. 1106(1):164–76.
125. Glass I. B. Alcoholic hallucinosis: a psychiatric enigma–1. The development of an idea. Br J Addict, 1989. 84(1):29–41.
126. Lanska D. J., Lanska M. J., Mendez M. F. Brainstem auditory hallucinosis. Neurology, 1987. 37(10):1685.
127. Cascino G. D., Adams R. D. Brainstem auditory hallucinosis. Neurology, 1986. 36(8):1042–7.
128. Lockwood A. H., Salvi R. J., Burkard R. F. Tinnitus. N Engl J Med, 2002. 347(12):904–10.
129. Waddell A. Tinnitus. Clin Evid, 2004(12):798–807.
130. Weissman J. L., Hirsch B. E. Imaging of tinnitus: a review. Radiology, 2000. 216(2):342–9.
131. Chan S. W., Reade P. C. Tinnitus and temporomandibular pain-dysfunction disorder. Clin Otolaryngol Allied Sci, 1994. 19(5):370–80.
132. Fox G. N., Baer M. T. Palatal myoclonus and tinnitus in children. West J Med, 1991. 154(1):98–102.
133. Muhlau M., et al. Structural brain changes in tinnitus. Cereb Cortex, 2006. 16(9):1283–8.
134. Eggermont J. J., Roberts L. E. The neuroscience of tinnitus. Trends Neurosci, 2004. 27(11):676–82.
135. Kandel E. R., Schwartz J. H., Jessell T. H. (2000). Principles of neural science. 4th ed. New York: McGraw-Hill Medical.
136. White P. M., et al. Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells. Nature, 2006. 441(7096):984–7.
137. Wiegand D. A., Ojemann R. G., Fickel V. Surgical treatment of acoustic neuroma (vestibular schwannoma) in the United States: report from the Acoustic Neuroma Registry. Laryngoscope, 1996. 106(1 Pt 1):58–66.
138. Henry J. A., Meikle M. B. Psychoacoustic measures of tinnitus. J Am Acad Audiol, 2000. 11(3):138–55.
139. Jastreboff P. J. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res, 1990. 8(4):221–54.
140. Chen G. D., Jastreboff P. J. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hear Res, 1995. 82(2):158–78.
141. Kaltenbach J. A., Zhang J., Finlayson P. Tinnitus as a plastic phenomenon and its possible neural underpinnings in the dorsal cochlear nucleus. Hear Res, 2005. 206(1–2):200–26.
142. Lockwood A. H., et al. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology, 1998. 50(1):114–20.
143. Muhlnickel W., et al. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA, 1998. 95(17):10340–3.
144. Giraud A. L., et al. A selective imaging of tinnitus. Neuroreport, 1999. 10(1):1–5.
145. Melcher J. R., et al. Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol, 2000. 83(2):1058–72.
146. Hilton M., Stuart E. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev, 2004(2): p. CD003852.
147. Hannan S. A., Sami F., Wareing M. J. Tinnitus. Br Med J, 2005. 330(7485): 237.
148. Webster R., Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics, 2000. 41(6):519–22.
149. Foy A., Kay J., Taylor A. The course of alcohol withdrawal in a general hospital. QJM, 1997. 90(4):253–61.
150. Lishman W. A. (1998). Organic psychiatry. The psychological consequences of cerebral disorder. 3rd ed. London: Blackwell Science.
151. Nayani T., David A. The auditory hallucination: a phenomenological survey. Psychol Med, 1996. 26:177–89.
152. Copolov D., Trauer T., Mackinnon A. On the non-significance of internal versus external auditory hallucinations. Schizophr Res, 2004. 69:1–6.
153. Junginger J., Frame C. Self-report of the frequency and phenomenology of verbal hallucinations. J Nerv Ment Dis, 1985. 173:149–55.
154. Oulis P., et al. Clinical characteristics of auditory hallucinations. Acta Psychiatr Scand, 1995. 92:97–102.
155. Shawyer F., et al. Command hallucinations and violence: implications for detention and treatment. Psychiatry Psychol Law, 2003. 10:97–107.
156. Fried I., Spencer D. D., Spencer S. S. The anatomy of epileptic auras: focal pathology and surgical outcome. J Neurosurg, 1995. 83(1):60–6.
157. McGuire P., et al. Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet, 1995. 346:596–600.
158. Shergill S., et al. Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. Am J Psychiatry, 2000. 157:1691–3.
159. Shergill S., et al. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry, 2000. 57:1033–8.
160. Lennox B., et al. The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res, 2000. 100:13–20.
161. Hunter M., et al. A neural basis for the perception of voices in external auditory space. Brain, 2002. 126:161–9.
162. Laviolette S. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? Schizophr Bull, 2007. 33:971–81.
163. Currie S., et al. Clinical course and prognosis of temporal lobe epilepsy. A survey of 666 patients. Brain, 1971. 94(1):173–90.
164. Mauguiere F. Scope and presumed mechanisms of hallucinations in partial epileptic seizures. Epileptic Disord, 1999. 1(2):81–91.
165. Williamson P. D., Spencer S. S. Clinical and EEG features of complex partial seizures of extratemporal origin. Epilepsia, 1986. 27(Suppl 2):S46–63.
166. Sachdev P. Schizophrenia-like psychosis and epilepsy: the status of the association. Am J Psychiatry, 1998. 155(3):325–36.
167. Fujii D., Ahmed I. Characteristics of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature. J Neuropsychiatry Clin Neurosci, 2002. 14(2):130–40.
168. Stewart B., Brennan D. M. Auditory hallucinations after right temporal gyri resection. J Neuropsychiatry Clin Neurosci, 2005. 17(2):243–5.
169. Shaw P., et al. Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry, 2004. 75(7):1003–8.
170. Cerrato P., et al. Complex musical hallucinosis in a professional musician with a left subcortical haemorrhage. J Neurol Neurosurg Psychiatry, 2001. 71(2):280–1.
171. Berrios G. E. Musical hallucinations. A historical and clinical study. Br J Psychiatry, 1990. 156:188–94.
172. Ffischer C., Marchie A., Norris M. Musical and auditory hallucinations: a spectrum. Psychiatry Clin Neurosci, 2004. 58(1):96–8.
173. Ffischer C., Ellger T. The clinical spectrum of musical hallucinations. J Neurol Sci, 2004. 227(1):55–65.
174. Griffiths T. D. Musical hallucinosis in acquired deafness. Phenomenology and brain substrate. Brain, 2000. 123 (Pt 10):2065–76.
175. Griffiths T. D., et al. Analysis of temporal structure in sound by the human brain. Nat Neurosci, 1998. 1(5):422–7.
176. Zatorre R. J., Evans A. C., Meyer E. Neural mechanisms underlying melodic perception and memory for pitch. J Neurosci, 1994. 14(4):1908–19.
177. Penhune V. B., Zattore R. J., Evans A. C. Cerebellar contributions to motor timing: a PET study of auditory and visual rhythm reproduction. J Cogn Neurosci, 1998. 10(6):752–65.
178. Murata S., Naritomi H., Sawada T. Musical auditory hallucinations caused by a brainstem lesion. Neurology, 1994. 44(1):156–8.
179. Schielke E., et al. Musical hallucinations with dorsal pontine lesions. Neurology, 2000. 55(3):454–5.
180. Douen A. G., Bourque P. R. Musical auditory hallucinosis from Listeria rhombencephalitis. Can J Neurol Sci, 1997. 24(1):70–2.
181. Nagaratnam N., Virk S., Brdarevic O. Musical hallucinations associated with recurrence of a right occipital meningioma. Br J Clin Pract, 1996. 50(1):56–7.
182. Stephane M., Hsu L. K. Musical hallucinations: interplay of degenerative brain disease, psychosis, and culture in a Chinese woman. J Nerv Ment Dis, 1996. 184(1):59–61.
183. Mocellin R., Walterfang M., Velakoulis D. Neuropsychiatry of complex visual hallucinations. Aust NZJ Psychiatry, 2006. 40(9):742–51.
184. Baba A., Hamada H. Musical hallucinations in schizophrenia. Psychopathology, 1999. 32(5):242–51.
185. Pearlson G. D., et al. A chart review study of late-onset and early-onset schizophrenia.[see comment]. Am J Psychiatry, 1989. 146(12):1568–74.
186. Kopala L. C., Good K. P., Honer W. G. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophrenia Res, 1994. 12(3):205–11.
187. Teggin A. F., et al. A comparison of CATEGO class ‘S’ schizophrenia in three ethnic groups: psychiatric manifestations. Br J Psychiatry, 1985. 147:683–7.
188. Ndetei D. M., Singh A. Hallucinations in Kenyan schizophrenic patients. Acta Psychiatr Scand, 1983. 67(3):144–7.
189. Ndetei D. M., Vadher A. A comparative cross-cultural study of the frequencies of hallucination in schizophrenia. Acta Psychiatr Scand, 1984. 70(6):545–9.
190. Jablensky A., et al. Schizophrenia: manifestations, incidence and course in different cultures. Psychol Med Monogr., 1992. Suppl 20:35–7.
191. Commission on Clasification and Terminology of the Intemational League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia, 1981(4). 22:489–501.
192. Lennox W. G., Cobb S. Epilepsy. XIII. Aura in epilepsy: A statistical review of 1359 cases. Arch Neurol Psychiatry, 1933. 30:374–87.
193. Gupta A.K., et al. Aura in temporal lobe epilepsy: clinical and electroencephalographic correlation. J Neurol, Neurosurg Psychiatry, 1983. 46:1079–83.
194. Jackson J. H., Stewart P. Epileptic attacks with a warning of a crude sensation of smell and the intellectual aura (dreamy state) in a patient who had symptoms pointing to gross organic disease of the right tempero-sphenoidal lobe. Brain Inj, 1899. 22:534–50.
195. Taylor D. C., Lochery M. Temporal lobe epilepsy: origin and significance of simple and complex auras. J Neurol, Neurosurg Psychiatry, 1987. 50:673–81.
196. Daly D. Uncinate fits. Neurology, 1958. 8:250–60.
197. Chen C., et al. Olfactory auras in patients with temporal lobe epilepsy. Epilepsia, 2003. 44(2):257–60.
198. Acharya V., Acharya J., Luders H. Olfactory epileptic auras. Neurology, 1998. 51(1):56–61.
199. Sandyk R. Olfactory hallucinations in Parkinson's disease. South African Medical Journal. Suid Afrikaanse Tydskrif Vir Geneeskunde, 1981. 60(25):19.
200. Goetz C. G., et al. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology, 1998. 51(3):811–4.
201. Holroyd S., Currie L., Wooten G. F. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry, 2001. 70(6):734–8.
202. Silberstein S. D., et al. Cluster headache with aura. Neurology, 2000. 54(1):219–21.
203. Fuller G. N., Guiloff R. J. Migrainous olfactory hallucinations. J Neurol, Neurosurg Psychiatry, 1987. 50(12):1688–90.
204. Nickell P. V., Uhde T. W. Dose-response effects of intravenous caffeine in normal volunteers. Anxiety, 1994. 1(4):161–8.
205. Koenigsberg H. W., Pollak C. P., Fine J. Olfactory hallucinations after the infusion of caffeine during sleep. Am J Psychiatry, 1993. 150(12):1897–8.
206. Siegel R. K. Cocaine hallucinations. Am J Psychiatry, 1978. 135(3):309–14.
207. Tien A. Distribution of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol, 1991. 26:287–92.
208. Heveling T., Emrich H., Dietrich D. Treatment of a rare psychopathological phenomenon: tactile hallucinations and the delusional other. Eur Psychiatry, 2004. 19:387–8.
209. Pfeifer L. A subjective report of tactile hallucinations in schizophrenia. J Clin Psychol, 1970. 26:57–60.
210. Salama A., England R. A case study: schizophrenia and tactile hallucinations, treated with electroconvulsive therapy. Can J Psychiatry, 1990. 35:86–7.
211. Bar K.-J., et al. Transient activation of a somatosensory area in painful hallucinations shown by fMRI. Neuroreport, 2002. 13:1–4.
212. Shergill S., et al. Modality specific neural correlates of auditory and somatic hallucinations. J Neurol Neurosurg Psychiatry, 2001. 71:688–90.
213. Munro A. Monosymptomatic hypochondriacal psychoses: a diagnostic entity which may respond to pimozide. Can Psychiatr Assoc J, 1978. 23:497–500.
214. Munro A. Monosymptomatic hypochondriacal psychosis manifesting as delusions of parasitosis. A description of four cases successfully treated by pimozide. Arch Dermatol, 1978. 114:940–3.
215. MacNamara P. Cutaneous and visual hallucinations. Lancet, 1928. 214:807–8.
216. Mallet R., Male P. Delire cenesthesique. Ann Med Psychol, 1930. 88:198–201.
217. Dupre E. Les cenestipathies. Mouvement Medical, 1913. 23:3–22.
218. Wilson J., Miller H. Delusions of parasitosis. Arch Dermatol Syph, 1946. 54:39–56.
219. Bhatia M., Jagawat T., Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med, 2000. 30:83–91.
220. Berrios G. Tactile hallucinations: conceptual and historical aspects. J Neurol Neurosurg Psychiatry, 1982. 45:285–93.
221. Claude H., Ey H. Troubles psychosensoriels et etats oniriques dans l'encephalite epidemique chronique. Presse Med (Paris), 1933. 104:1281–5.
222. Fenelon G., et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain, 2000. 123:733–45.
223. Fenelon G., et al. Tactile hallucinations in Parkinson's disease. J Neurol, 2002. 249:1699–703.
224. Murthy P., Jayakumar P., Sampat S. Of insects and eggs: a case report. J Neurol Neurosurg Psychiatry, 1997. 63:522–3.
225. Chang P., Steinberg M. Alcohol withdrawal. Med Clin North Am, 2001. 85:1191–212.
226. Driessen M., et al. Proposal of a comprehensive clinical typology of alcohol withdrawal – a cluster analysis approach. Alcohol, 2005. 40:308–13.
227. Limosin F., et al. The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neurosci Lett, 2004. 362:9–14.
228. Flaum M., Schultz S. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry, 1996. 153:812–15.
229. Nordahl T., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci, 2003. 15:317–25.
230. Di Forti M., Lappin J., Murray R. Risk factors for schizophrenia – all roads lead to dopamine. Eur Neuropsychopharmacol, 2007. 17:S101–S107.
231. Raedler T., et al. Towards a muscarinic hypothesis of schizophrenia. Mol Psychiatry, 2007. 12:232–46.
232. Tandon R. Cholinergic aspects of schizophrenia. Br J Psychiatry, 1999. 37:7–11.
233. Pantelis C., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull, 2005. 31:672–96.
234. Keshavan M., et al. Neurobiology of early psychosis. Br J Psychiatry, 2005. 48:S8–18.